 MINNEAPOLIS, Aug. 30, 2021 GLOBE NEWSWIRE -- Inspire Medical Systems, Inc. NYSE: INSP Inspire, a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that a Centers for Medicare and Medicaid Services CMS panel has unanimously approved a recommendation to increase the previously proposed reimbursement for Inspire procedure performed in Ambulatory Surgical Centers ASCs as indicated on the CMS website as posted today. 